urea has been researched along with Arteriosclerosis Obliterans in 1 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walton, KW | 1 |
| Craig, GM | 1 |
| Prior, P | 1 |
| Waterhouse, JA | 1 |
| Skilton, J | 1 |
1 trial available for urea and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
Topics: Arteriosclerosis Obliterans; Blood Cell Count; Bradykinin; Carbamates; Cholesterol; Clinical Trials | 1973 |